Three IPOs raised $2.3 billion this past week, led by Dun & Bradstreet's (DNB) billion-dollar deal. All three IPOs upsized their deals and priced above the range. Commercial data analytics provider Dun & Bradstreet (DNB) raised...read more
Panacea Acquisition, a blank check company formed by EcoR1 Capital targeting the biotech industry, raised $125 million by offering 12.5 million units at $10. Each unit consists of one share of common stock and one-third of a warrant; whole warrants are...read more
Panacea Acquisition, a blank check company formed by EcoR1 Capital targeting the biotech industry, filed on Friday with the SEC to raise up to $125 million in an initial public offering. The company plans to raise an additional $25 million through a forward...read more
US IPO Weekly Recap: 3 IPOs close out the 2Q in shortened holiday week
Three IPOs raised $2.3 billion this past week, led by Dun & Bradstreet's (DNB) billion-dollar deal. All three IPOs upsized their deals and priced above the range. Commercial data analytics provider Dun & Bradstreet (DNB) raised...read more
EcoR1's SPAC Panacea Acquisition prices $125 million IPO at $10
Panacea Acquisition, a blank check company formed by EcoR1 Capital targeting the biotech industry, raised $125 million by offering 12.5 million units at $10. Each unit consists of one share of common stock and one-third of a warrant; whole warrants are...read more
US IPO Weekly Recap: Vroom soars in another 8 IPO week
Eight IPOs and one SPAC entered the public markets this past week led by Vroom (VRM), which popped 118% in ...read more
EcoR1's biotech SPAC Panacea Acquisition files for a $125 million IPO
Panacea Acquisition, a blank check company formed by EcoR1 Capital targeting the biotech industry, filed on Friday with the SEC to raise up to $125 million in an initial public offering. The company plans to raise an additional $25 million through a forward...read more